3-Isopropoxy-5-methoxyphenylboronic acid, pinacol ester

Catalog No. :
ACMETI136
CAS No. :
2096329-95-0
Molecular Formula :
C16H25BO4
Molecular Weight :
292.18

IUPAC Name:2-(3-isopropoxy-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

3-Isopropoxy-5-methoxyphenylboronic acid, pinacol ester structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$52.00Login to see priceIn stockInquiry
250mg96%$82.00Login to see priceIn stockInquiry
1g96%$206.00Login to see priceIn stockInquiry
5g96%$1027.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Isopropoxy-5-methoxyphenylboronic acid, pinacol ester
IUPAC Name2-(3-isopropoxy-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC16H25BO4
Molecular Weight292.18
SMILESCOC1=CC(OC(C)C)=CC(B2OC(C)(C)C(C)(C)O2)=C1
InChI KeyDFTUUNAEKXIMST-UHFFFAOYSA-N
Synonym3-ISOPROPOXY-5-METHOXYPHENYLBORONIC ACID, PINACOL ESTER;1,3,2-Dioxaborolane, 2-[3-methoxy-5-(1-methylethoxy)phenyl]-4,4,5,5-tetramethyl-
CAS No.2096329-95-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMETI136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMETI136 route product structure diagram
    ACMETI1362096329-95-0 In Stock
Inquiry

2. ACMETI136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. ACDTUP098 route compound structure diagram
    ACDTUP098906008-22-8 In Stock
  4. Then
  5. ACMETI136 route product structure diagram
    ACMETI1362096329-95-0 In Stock
Inquiry

Comments (0)